GHOST Greens
Natural health product licensed in Canada
- Licence holder
- Ghost
- NPN or DIN-HM
- 80112847
- Status
- Active licence
- Licence date
- 14 September 2021
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Protéase fongique | 21,000 FCC HUT | Not calculated |
| Protéase Source : Protéase fongique | 39 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 21,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 39 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Avena sativa Source : Feuille | 250 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 200 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 3 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 200 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 3 mg | Not calculated |
| Solanum lycopersicum Source : Chair (fruit) | 4.28 mg | Not calculated |
| Inuline Source : Cichorium intybus - racine | 2,000 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Quercétine | 4.58 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 3,500 FCC DU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 150 FCC GalU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 10 mg | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 400 FCC SU | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 4.6 mg | Not calculated |
| Protéase Source : Protéase fongique | 2 FCC SAP | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 2 FCC SAP | Not calculated |
| Protéase Source : Protéase fongique | 7 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 7 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 305.5 mg Potency : 70 % Catechins | 12.22 mg | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 0.83 mg | Not calculated |
| Saccharomyces boulardii Source : En entier | 250 Millions d'UFC | Not calculated |
| Saccharomyces boulardii Source : DBVPG 6763 | 250 Millions d'UFC | Not calculated |
| Cinnamomum aromaticum Source : Écorce (tige) | 2.03 mg | Not calculated |
| Protease Source : Aspergillus flavus var. oryzae - En entier | 50 FCC SAP | Not calculated |
| Protease Source : Aspergillus flavus var. oryzae - En entier | 9.41 mg | Not calculated |
| Protease Source : Protéase fongique | 50 FCC SAP | Not calculated |
| Protease Source : Protéase fongique | 9.41 mg | Not calculated |
| Spinacia oleracea Source : Feuille | 0.86 mg | Not calculated |
| Chlorella vulgaris Source : Cellule brisée | 500 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 350 mg | Not calculated |
| Brassica oleracea var. italica Source : Sommité (herbe) | 113.95 mg | Not calculated |
| Malus domestica Source : Fruit Extract : Matériel brut sec Extraction ratio : 85:1 Dry plant equivalent : 692.75 mg | 8.15 mg | Not calculated |
| Brassica oleracea var. gemmifera Source : Bourgeon de feuille | 0.06 mg | Not calculated |
| Curcuma longa Source : Rhizome | 2.03 mg | Not calculated |
| Lycium barbarum Source : Fruit | 100 mg | Not calculated |
| Camellia sinensis Source : Feuille | 500 mg | Not calculated |
| Medicago sativa Source : Feuille | 250 mg | Not calculated |
| Daucus carota Source : Racine | 1.57 mg | Not calculated |
| Bacillus coagulans Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bacillus coagulans Source : SNZ1969 | 1 Milliards d'UFC | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 1,390 mg | Not calculated |
| Arthrospira platensis Source : En entier | 500 mg | Not calculated |
| Hordeum vulgare Source : Feuille | 250 mg | Not calculated |
| Allium sativum Source : Bulbe | 2.03 mg | Not calculated |
| Lactobacillus acidophilus Source : La-14 | 2.5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 2.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Saveur de lime, Extrait de feuille de Stevia Rebaudiana, Fruit de Sambucus nigra, Poly(dextrose), Fruit de Jaboticaba, Acide citrique, Maltodextrine, Saveur de fruit naturelle, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support and maintain a healthy digestive system. Source of fiber for the maintenance of good health. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Digestive enzyme(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80112847
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.